Emerging research is reshaping understanding of how transcranial magnetic stimulation (TMS) therapy works for patients with depression, particularly those who have not responded to traditional medications. During a behavioral health summit discussion in Dallas, experts highlighted new insights into the mechanism behind TMS effectiveness, drawing on research from Stanford University.
According to emerging research from Stanford University, depression is increasingly understood as a disorder of dysfunctional brain signaling rather than solely a chemical imbalance. TMS works by delivering magnetic pulses that may help disrupt and recalibrate abnormal patterns of neural communication in regions of the brain associated with mood regulation. “It is believed that magnetic pulses from the TMS coil may reverse the direction of abnormal brain signals,” explained one clinical expert during the discussion. Unlike medication, which acts systemically throughout the body, TMS targets specific regions of the brain associated with mood, motivation, and executive function.
The ability to study changes in brain activity in real time has been advanced by developments in functional brain imaging. Researchers reference the work of Dr. Mark Raichle of St. Louis, Missouri, who developed a mathematical framework for analyzing functional magnetic resonance imaging (fMRI). This framework enables researchers to observe how entire brain networks communicate in real time and has contributed to advances in neuroscience and psychiatry.
Advances in neuromodulation and functional brain imaging are moving psychiatry toward more precise, individualized care, with ongoing research aimed at identifying measurable biomarkers for depression. TMS’s targeted, non-invasive approach has positioned it as an important treatment option for patients who have not experienced adequate relief through conventional therapies. Restore Brain, a multi-state interventional behavioral health practice, specializes in advanced treatments for depression, including TMS therapy and other evidence-based neuromodulation approaches, currently serving patients in Dallas, Texas, and St. Louis, Missouri.
This article is an AI-assisted summary. All facts and figures are drawn from the original report: https://www.benzinga.com/pressreleases/26/02/g50499996/restore-brain-highlights-new-insights-on-how-tms-therapy-works-following-dallas-behavioral-health-